Overview

Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective treatment for esophageal cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy in treating patients with Barrett's esophagus who have in situ esophageal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Roswell Park Cancer Institute
Treatments:
Dihematoporphyrin Ether
Trioxsalen